Duplicate_Oasis Clinical Research, LLC /ID# 267953 — Las Vegas, Nevada

Duplicate_Oasis Clinical Research, LLC /ID# 267953 is a clinical research site located in Las Vegas, Nevada, United States 89121.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Duplicate_Oasis Clinical Research, LLC /ID# 267953 has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Generalized Anxiety Disorder (GAD), Bipolar I Disorder, Bipolar II Disorder.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Las Vegas

Browse all research sites in Nevada · View every site in Las Vegas

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duplicate_Oasis Clinical Research, LLC /ID# 267953?

Duplicate_Oasis Clinical Research, LLC /ID# 267953 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duplicate_Oasis Clinical Research, LLC /ID# 267953 conducted?

Duplicate_Oasis Clinical Research, LLC /ID# 267953 has 2 clinical trials on record, with 1 currently active. Their work covers Generalized Anxiety Disorder (GAD), Bipolar I Disorder, Bipolar II Disorder.

Is Duplicate_Oasis Clinical Research, LLC /ID# 267953 accredited by Crixeo Clinical Trials?

Duplicate_Oasis Clinical Research, LLC /ID# 267953 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duplicate_Oasis Clinical Research, LLC /ID# 267953?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.